Skip to content

    Uterine Fibroids Health Center

    Font Size

    Sales Halted for Uterine-Fibroid Surgery Device

    WebMD News from HealthDay

    May 1, 2014 -- Sales of a device used in surgery to remove uterine fibroids have been halted due to concerns that they may worsen a rare but deadly type of cancer, Johnson & Johnson said Tuesday.

    The company noted that while worldwide sales, distribution and promotion of the device -- called a morcellator -- have been suspended, it will not be taken off the market, the Wall Street Journal reported.

    J&J took the action after the U.S. Food and Drug Administration warned doctors on April 17 that using a morcellator to remove uterine fibroids risked worsening a type of cancer called uterine sarcoma.

    The FDA said 1 in 350 women who undergo uterine fibroid surgery have undetected uterine sarcoma, WSJ reported.

    An FDA advisory committee will meet this summer to more closely examine morcellator use during uterine fibroid surgery. In a letter to customers, J&J said it was awaiting input from the FDA and the medical community.

    Today on WebMD

    uterine fibroid illustration
    Symptoms and treatments.
    uterus and ovary
    Is location in the uterus a factor?
    doctor holding model of female reproductive system
    Surgical options for fibroids.
    pregnant woman
    Can complications occur?
    Period Cramping Your Style
    uterus and inlay of fibroids
    estrogen gene
    Comparing Birth Control Pill
    woman sitting on floor in pain
    woman looking at ultrasound
    Teenage girl with heat pad on stomach
    woman exercising

    WebMD Special Sections